Q & A with A & V Livestream 4/13/22
Virologists Amy Rosenfeld and Vincent Racaniello answer your COVID-19 questions (or any virus questions) on this livestream of 4/13/22 at 8:30 PM eastern US. (Source: virology blog)
Source: virology blog - April 14, 2022 Category: Virology Authors: Vincent Racaniello Tags: Q&A with A&V antiviral coronavirus COVID-19 delta inflammation Long Covid monoclonal antibody Omicron pandemic SARS-CoV-2 vaccine vaccine booster variant of concern virology viruses Source Type: blogs
Reporting FinCEN ’s Suspicious Activity
Nicholas AnthonyFinCEN, or the Financial Crimes Enforcement Network, will be appearing before Congress in an oversight hearing onApril 28th. Typically, these hearings serve as a time for elected officials to publicly question regulators about their conduct, their regulatory agency, and the economy at large. Although the questioning will likely focus on thesanctions on Russia and the rise of cryptocurrencies, representatives should be firm in their questioning over why FinCEN does not publicly provide evidence of its purported effectiveness.Currently, the public has no way of verifying how successful FinCEN ––and the ...
Source: Cato-at-liberty - April 13, 2022 Category: American Health Authors: Nicholas Anthony Source Type: blogs
Multi-Purpose Sensor for Rapid, Accurate COVID-19 Testing
Researchers at Johns Hopkins University developed a COVID-19 testing technology that is based on surface enhanced Raman spectroscopy (SERS) coupled with machine learning. The technique does not require sample preparation or special training and can deliver results in as little as 25 minutes, with an accuracy that is comparable to that of PCR, the current gold standard. Interestingly, the sensor material can be deployed in a standard chip format for personalized testing, but it can also be applied to frequently touched surfaces, such as door handles, or even as a wearable, to monitor environmental and personal viral exposur...
Source: Medgadget - April 11, 2022 Category: Medical Devices Authors: Conn Hastings Tags: Diagnostics Medicine Public Health jhu johnshopkins Source Type: blogs
What's new in midwifery - research - 11th April 2022
COVIDAssociation of COVID-19 vaccination in pregnancy with adverse peripartum outcomes, study carried out in Canada looking at primarily mRNA vaccines given in second and third trimester, comparing with vaccination given after pregnancy or no vaccination given, found no significant association.Retrospective cohort study of association of SARS-CoV-2 vaccination during pregnancy with pregnancy outcomes, " In this population-based retrospective cohort study that included 157 521 deliveries in Sweden and Norway, SARS-CoV-2 vaccination during pregnancy, compared with no SARS-CoV-2 vaccination during pregnancy, was no...
Source: Browsing - April 11, 2022 Category: Databases & Libraries Tags: midwifery Source Type: blogs
TWiV 887: Bonfire of the monocytes
TWiV explains why this season's influenza vaccine is not protecting against mild to moderate disease caused by H3N2 virus, and that antibody-dependent entry of SARS-CoV-2 into monocytes is a major contributor to severe COVID-19. (Source: virology blog)
Source: virology blog - April 10, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antibody dependent enhancement coronavirus COVID-19 Fc receptor fucosylation glycosylation H3N2 inflammation influenza vaccine pandemic SARS-CoV-22 viral viruses Source Type: blogs
TWiV 886: COVID-19 clinical update #109 with Dr. Daniel Griffin
In COVID-19 clinical update #109, Daniel Griffin discusses cardiac complications after infection or vaccination, long COVID in children, fourth vaccine dose in Israel, no need for fourth vaccine dose in EU, dexamethasone dosing, immunomodulation therapy, MIS outcomes in children, US long COVID effort launched, and herd immunity. (Source: virology blog)
Source: virology blog - April 9, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation Long Covid monoclonal antibody Omicron pandemic SARS-CoV-2 vaccine vaccine booster variant of concern viruses Source Type: blogs
Before taking Paxlovid, consider these drug interactions
FDA and Health Canada recently approved Paxlovid as an oral treatment option for mild-to-moderate COVID-19 who are at high risk of progression to severe COVID-19. It is a combination drug containing nirmatrelvir/ritonavir. Nirmatrelvir works by binding to SARS-CoV-2 3CL protease to ultimately stop viral replication. Ritonavir does not have any antiviral activity against COVID-19 butRead more …Before taking Paxlovid, consider these drug interactions originally appeared inKevinMD.com. (Source: Kevin, M.D. - Medical Weblog)
Source: Kevin, M.D. - Medical Weblog - April 7, 2022 Category: General Medicine Authors: < span itemprop="author" > < a href="https://www.kevinmd.com/post-author/param-patel" rel="tag" > Param Patel, PharmD < /a > < /span > Tags: Meds COVID Infectious Disease Medications Source Type: blogs
TWiV 885: Russian bats and Ankara vectors
TWiV reveals an ACE2-dependent sarbecovirus from Russian bats that is not inhibited by anti-SARS-CoV-2 antibodies, and a modified vaccinia virus Ankara vectored vaccine that protects nonhuman primates from Delta infection. (Source: virology blog)
Source: virology blog - April 7, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology ACE2 bat coronavirus COVID-19 pandemic SARS-CoV-2 vaccine vaccinia virus vector viral viruses Source Type: blogs
Q & A with A & V Livestream 4/6/22
Virologists Amy Rosenfeld and Vincent Racaniello answer your COVID-19 questions (or any virus questions) on this livestream of 4/6/22 at 8:30 PM eastern US. (Source: virology blog)
Source: virology blog - April 7, 2022 Category: Virology Authors: Vincent Racaniello Tags: Q&A with A&V antiviral coronavirus COVID-19 delta inflammation Long Covid monoclonal antibody Omicron pandemic SARS-CoV-2 vaccine vaccine booster variant of concern virology viruses Source Type: blogs
Fight Aging! Newsletter, April 4th 2022
Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter,
please visit:
https://www.fightaging.org/newsletter/
Longevity Industry Consulting Services
Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out m...
Source: Fight Aging! - April 3, 2022 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs
TWiV 884: Cytokines and viral mimicry
Vincent and Amy explain how asthmatic bronchial smooth muscle increases rhinovirus replication in the bronchial epithelium, and mimicry of IL-17 by the ORF8 protein of SARS-CoV-2. (Source: virology blog)
Source: virology blog - April 3, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology asthma coronavirus COVID-19 inflammation mRNA vaccine pandemic rhinovirus viral viruses Source Type: blogs
TWiV 883: COVID-19 clinical update #108 with Dr. Daniel Griffin
In clinical update #107, Daniel Griffin reviews vaccine booster doses, at-home testing, transmission in hamsters, improving indoor air quality, trials of BCG, ivermectin, and fluvoxamine, vaccination during pregnancy, mRNA vaccines and Fc functions, anti-platelet and aspirin therapy and a trial of prone positioning. (Source: virology blog)
Source: virology blog - April 2, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation Long Covid monoclonal antibody Omicron pandemic SARS-CoV-2 vaccine vaccine booster variant of concern viruses Source Type: blogs
Q & A with A & V Livestream 3/30/22
Virologists Amy Rosenfeld and Vincent Racaniello answer your COVID-19 questions (or any virus questions) on this livestream of 3/30/22 at 8:30 PM eastern US. (Source: virology blog)
Source: virology blog - March 31, 2022 Category: Virology Authors: Vincent Racaniello Tags: Q&A with A&V antiviral coronavirus COVID-19 delta inflammation Long Covid monoclonal antibody pandemic SARS-CoV-2 vaccine vaccine booster variant of concern virology viruses Source Type: blogs
An Example of a Very Targeted, Narrow Improvement of Immune Function in Aged Individuals
There are many potential approaches to interfere in the sweeping age-related chances to immune function. Of these, many stem from epigenetic changes characteristic of age, causing dysregulation via too much or too little production of a given protein, rather than more structural issues relating to reduced production of immune cells and increasing wear and tear of populations of immune cells lacking reinforcements. In this arena, a more efficient small molecule drug discovery process can allow for incremental improvement in immune function, assuming one can find a single point of intervention that has a high yield outcome i...
Source: Fight Aging! - March 28, 2022 Category: Research Authors: Reason Tags: Daily News Source Type: blogs
TWiV 881: 50 ways to zap your virus
TWiV describes the identification of a monoclonal antibody that provides broad protection against a variety of hantaviruses, and development of an oral remdesivir-like antiviral that ameliorates viral disease in mice. (Source: virology blog)
Source: virology blog - March 27, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology COVID-19 epitope hantavirus monoclonal antibody oral antiviral pandemic remdesivir SARS-CoV-2 viruses Source Type: blogs
